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Abstract 
Cognition is considered a key predictor of community outcome in schizophrenia and is the target 
of an increasingly large number of pharmacological and behavioural interventions. The 
proliferation of functional capacity instruments grew out of the need to introduce a co-primary 
measure in intervention studies that was associated with cognition, related to community 
outcome, and face valid (Buchanan et al., 2005). While use of functional capacity measures has 
increased substantially, there is much variability in how this construct is understood and utilized. 
Theoretically, this ability is distinct from cognition; however, this distinction has not been 
established empirically. The current research examined the widely-held notion that functional 
capacity and cognition represent distinct constructs. This was achieved by performing an 
exploratory factor analysis on cognitive and functional capacity measures in an archival dataset 
(n = 96) followed by a confirmatory factor analysis on data collected at a second time-point (n = 
95). Unlike previous studies, cognitive tests included in the analysis represented all cognitive 
domains claimed to be separable (Nuechterlein et al., 2004) and applied best practices for 
exploratory factor analysis (Costello & Osborne, 2005). The results indicated that cognition and 
functional capacity are determined by the same latent construct and should not be considered 
distinct. These results were then replicated with a second archival dataset (n = 155 and n = 128) 
which utilized different measures of cognition and functional capacity. Given that functional 
capacity instruments are redundant with cognitive measures, efforts will need to be invested into 
investigating alternative co-primary measures. Reaching a consensus on a co-primary measure 
will support the development of treatments aimed at improving community outcome. 
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Predictors of Community Outcome in Schizophrenia: The Factor Structure of Cognition and 
Functional Capacity 
Schizophrenia is among the top most globally burdensome illnesses (World Health 
Organization, 2008) with only one in seven individuals demonstrating recovery in clinical and 
social functioning domains (Jääskeläinen et al., 2013). Indeed, reducing disability in this 
population remains a research and clinical challenge. This mental disease interferes with 
patients’ ability to achieve educational milestones (Kessler, Foster, Saunders, & Stang, 1995) 
and subsequently maintain employment (Mueser, Salyers, & Mueser, 2001; Tsang, Leung, 
Chung, Bell, & Cheung, 2010). Accordingly, many individuals with schizophrenia live in 
poverty (Draine et al., 2002). Patients are also unlikely to live independently and have difficulty 
obtaining and even maintaining supported housing (Jaeger et al., 2015). Deficiency in 
understanding social behaviour is another characteristic of schizophrenia and contributes to 
impairments in community functioning, quality of life, and the social skills necessary for 
interaction with peers and clinicians (Couture, Penn, & Roberts, 2006). Together, functional 
impairments in community activities including academic, social, occupational, and independent 
living domains contribute to the high burden and disability associated with schizophrenia.  
Extensive resources have been invested into research and clinical initiatives aimed at 
improving community outcome and thereby reducing functional disability in schizophrenia. 
Despite major advancements in treatments, the proportion of recovered cases has not increased in 
recent decades (Jääskeläinen et al., 2013). To address continued poor functionality in 
schizophrenia, research has focused on identifying determinants of community outcome. 
Attempts to understand this phenomenon have identified cognition as the best predictor of 
outcome (Green, Kern, & Heaton, 2004a). However, the US Food and Drug Administration 
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(FDA) noted that cognitive measures were limited in their predictive and face validity, leading 
them to require a more functionally meaningful co-primary (i.e., additional) measure of 
treatment effect on community outcome (Buchanan et al., 2005). In other words, for treatments 
to receive FDA approval, improvement must be demonstrated on cognitive measures as well as a 
measure that reflects abilities more obviously related to daily living than cognition. This 
requirement led to the proliferation of a new construct called functional capacity. Functional 
capacity refers to one’s repertoire of daily living skills, as demonstrated by performance in ideal 
environments (i.e., free from environmental and social barriers). Although use of functional 
capacity measures has proliferated in recent years, evidence regarding whether they serve their 
intended purpose is conflicting. Some research has indicated that capacity measures add 
predictive validity over and above cognitive measures and mediate the relationship between 
cognition and community outcome (e.g., Bowie, Reichenberg, Patterson, Heaton, & Harvey, 
2006; McDermid Vaz et al., 2013) while other evidence suggests that the two constructs overlap 
substantially and that functional capacity measures do not demonstrate incremental validity (e.g., 
Heinrichs, Ammari, Miles, & McDermid Vaz, 2010; Muharib et al., 2014). This conflicting state 
of community outcome research has prompted the need for a critical reappraisal of the 
relationship between cognition and functional capacity and the value of including both cognitive 
and capacity measures in predicting community outcome. 
The Importance of Cognition in Schizophrenia 
Cognitive impairment is widely regarded as a core deficit in schizophrenia. These deficits 
are detectable in high-risk groups prior to the onset of psychosis (Seidman et al., 2006; 2010), at 
first-episode (Mesholam-Gately, Giuliano, Goff, Faraone, & Seidman, 2009), and throughout the 
lifespan (Herold, Schmid, Lässer, Seidl, & Schröder, 2017). Patients perform at least one 
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standard deviation, and sometimes up to 2.5 standard deviations, below controls across numerous 
neuropsychological tests (Heinrichs & Zakzanis, 1998; Keefe et al., 2011; Schaefer, Giangrande, 
Weinberger, & Dickinson, 2013). Specifically, seven cognitive domains have been demonstrated 
as consistently impaired in this population: verbal comprehension, processing speed, attention, 
working memory, verbal memory, visual memory, and reasoning (Nuechterlein et al., 2004). 
While cognitive disturbances have been highlighted in this population since the 
establishment of schizophrenia as a mental illness (Kraepelin, 1919), the relative importance 
attributed to cognition today is largely due to its potential for mediating important aspects of 
community adjustment (Bowie & Harvey, 2006; Green et al., 2004a; Keefe & Harvey, 2012). 
Not only is cognition regarded as the strongest predictor of community outcome, but cognitive 
domains also differentially predict aspects of community independence (see Keefe & Harvey, 
2012, for a review). For example, engagement in community activities and residential status is 
predicted by verbal memory abilities, social functioning is predicted by sustained attention, and 
daily living skills, vocational productivity, and social competence are predicted by executive 
functioning (Velligan, Bow-Thomas, Mahurin, Miller, & Halgunseth, 2000). Provided that key 
cognitive domains are amenable to change, interventions targeting cognition have the potential to 
influence community outcome and reduce the disability associated with schizophrenia.  
The effects of research suggesting that improvements in cognition will reduce disability 
is reflected in the recent proliferation of cognitive remediation programs (Kurzban, Brekke, & 
Davis, 2010) and pharmacological initiatives (Brady, Winsky, Goodman, Oliveri, & Stover, 
2009). Indeed, there now exists a large variety of cognitive remediation programs (McGurk & 
Mueser, 2013) and sizeable resources have been invested into their development, 
implementation, and evaluation. Likewise, large investments have been made by the 
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pharmacological industry into the development of treatments that address cognitive impairments 
in schizophrenia. These behavioural and pharmacological initiatives are designed with the 
premise that improving cognition results in improved community outcome. However, the 
research demonstrating the effectiveness of these initiatives is limited. Instead, research has 
demonstrated that while cognitive skills training programs may improve cognition, these gains 
do not necessarily translate into improvements in community outcome (Dickinson et al., 2010; 
Green & Harvey, 2014). Instead, large-scale meta-analyses have suggested that it is the addition 
of psychiatric rehabilitation services (e.g., social or vocational skills training), and not the 
cognitive interventions per se, that bolster community outcomes (McGurk, Twamley, Sitzer, 
McHugo, & Mueser, 2007; Wykes, Huddy, Cellard, McGurk, & Czobor, 2011). Moreover, 
patients that show the greatest benefits from such interventions are those with better baseline 
cognitive performance (Farreny et al., 2016; Kurtz, 2011; Vita et al., 2013), meaning that the 
most cognitively disadvantaged patients, and presumably those with the most disability, remain 
impaired in their community functioning. Even when treatment gains associated with such 
interventions are made, the effect sizes are small to moderate across even the most 
methodologically rigorous cognitive remediation programs (Wykes et al., 2011) and there is little 
research to support the long-term maintenance of these gains (McGurk et al., 2007). 
Additionally, research suggests that advantages in cognitive abilities are associated with better 
functional capacity (i.e., skills) but not functioning in the community (Muharib et al., 2014). 
These results warrant the critical reappraisal of cognition as a driver of outcomes and have 
triggered the current investigation into the role of cognition in schizophrenia.  
Indeed, several key challenges exist in the literature. First, although the consensus view 
maintains that cognition predicts community outcome, cognition alone accounts for a small 
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fraction of variance, with a recent meta-analysis demonstrating that only as much as 16% of 
variance in outcome is explained by cognition (Fett et al., 2011). Nevertheless, other studies have 
reported larger effect sizes, noting that 20 to 60% of variance in outcome can be explained by 
cognition (Green, Kern, Braff, & Mintz, 2000). To advance the field, the relationship between 
cognition and community outcome needs to be re-examined. Additionally, research in the field 
has yet to identify which variables account for the unexplained variance and how cognition and 
other key variables relate to community outcome. Understanding these relationships will 
ultimately allow for the design and implementation of treatments that target mediators of 
outcome and thereby reduce disability. Accordingly, the current study investigated these 
relationships. 
The Relationship between Cognition and Functional Capacity 
Functional capacity, or the repertoire of daily living skills an individual possesses and is 
able to demonstrate, is a construct that has been developed to link cognition and community 
outcome. Functional capacity differs from community outcome in that it purportedly reflects 
what a person is capable of doing in an ideal environment as opposed to how they actually 
perform in the “real” world. This construct developed following concerns about the ecological 
validity of other assessment methods of functioning in patients with severe mental illnesses 
(Harvey, Velligan, & Bellack, 2007; Patterson, Goldman, McKibbin, Hughs, & Jeste, 2001). 
Specifically, self-reports are subject to bias, particularly in individuals with severe mental 
illnesses who typically have limited insight, and informant reports are not available for many 
people with schizophrenia as they either lack key informants or have limited contact with them 
(Brown & Velligan, 2016; Harvey et al., 2007). Additionally, direct observation of functioning 
would be impractical as a high time investment would be required to observe behaviours that 
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occur infrequently in this population such as, for example, handling a power outage in one’s 
home. In an attempt to create more objective, reliable, and functionally valid indices of 
community outcome, the University of California San Diego (UCSD) Performance-Based Skills 
Assessment Battery (UPSA; Patterson et al., 2001) and similar performance-based measures of 
functional capacity such as the Canadian Objective Assessment of Life Skills (COALS; 
McDermid Vaz et al., 2013) were developed. Such measures have trained researchers and 
clinicians observe patients roleplay real-life tasks such as transportation scheduling or meal 
planning in a laboratory environment.  
Following pressure from the US FDA to include a clinically meaningful and face valid 
co-primary outcome measure of functional improvement in intervention studies (Buchanan et al., 
2005), use of functional capacity measures has proliferated. While these instruments are meant to 
act as proxy measures of functioning in the community (i.e., what an individual could do in the 
community; Buchanan et al., 2005), there is much variability in how this construct is understood 
and utilized. For example, some researchers have erroneously used capacity measures 
interchangeably with or instead of measures of community outcome (e.g., Fett et al., 2011), 
others have reported that functional capacity mediates the relationship between cognition and 
outcomes (e.g., Bowie et al., 2006), and others yet have suggested that they may be redundant 
with measures of cognitive abilities (e.g., Harvey et al., 2013, 2016; Heinrichs et al., 2010). 
In light of its popularity and theorized utility, the nature of this construct and its relation 
to cognition requires further clarification. More specifically, use of this construct has increased 
as a result of its presumed ability to better predict changes that may lead to improvements in 
community outcome. Additionally, many study designs and associated interpretations of research 
findings are contingent upon the idea that cognition and functional capacity represent distinct, 
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but related, constructs. For example, Bowie and colleagues (2006) collected functional capacity, 
cognitive, symptom, and community outcome data on schizophrenia patients and used 
confirmatory path analyses to examine how neuropsychological performance is related to 
community outcome. The researchers concluded that functional capacity mediates the 
relationship between cognition and most aspects of community functioning (e.g., interpersonal 
skills, community activities, and work skills) but cautioned that functional capacity measures 
require cognitive skills and thus reported that measurement error was introduced in predicting 
capacity performance. This limitation is particularly relevant as the conclusions of this and other 
studies were based on the implicit assumption that functional capacity and cognition represent 
distinct constructs. However, the validity of this assumption is largely untested and hence the 
conclusions of such studies may be inaccurate. 
Given that cognition and functional capacity are both considered key correlates of 
outcomes, elucidating the nature of these constructs will allow for a better understanding of the 
complex phenomenon of community outcome. Nuechterlein and colleagues (2004) suggest that 
the highest level of support for independence of abilities is evidence of distinct neural 
underpinnings that respond differently to pharmacological interventions. Alternatively, 
independence of abilities may be established statistically through factor analytic studies and 
weak correlations (e.g., r  < .4; Nuechterlein et al., 2004); the present study attempts to address 
the nature of these abilities through these statistical methods.  Of note, existing research has not 
demonstrated that cognition and functional capacity are separate abilities but, instead, suggests 
that performances on tasks measuring these abilities are strongly correlated and may even be 
determined by the same underlying processes (e.g., Harvey et al., 2013, 2016).  
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Multiple lines of research have indicated that the constructs of cognition and functional 
capacity are highly overlapping. Indeed, strong positive correlations have been consistently 
demonstrated between tests of functional capacity and a broad range of neuropsychological 
measures (e.g., Bowie et al., 2006; Keefe, Poe, Walker, & Harvey, 2006; Twamley et al., 2002). 
Despite the use of different cognitive measures, the correlation between performance on a range 
of traditional neuropsychological tasks and the UPSA is typically in the r = .60 to r = .65 range 
(Leifker, Patterson, Heaton, & Harvey, 2011) and sometimes reaches as high as .79 (Pietrzak et 
al., 2009). To put this figure into perspective, a meta-analysis of between-domain correlations 
across neuropsychological tasks used in the schizophrenia literature found that the average 
correlation between cognitive measures was r = .37, with a range of r = .24 to r = .49 (Dickinson 
& Gold, 2008). Similar correlations can be found among other cognitive tests, such as those 
contained within the Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV; Wechsler, 
2008), whereby correlations between WAIS-IV tests are typically in the r = .4 to r = .5 range. 
Thus, not only are correlations between cognition and functional capacity substantial, but they 
are higher than typical correlations across neuropsychological measures and cognitive domains. 
Other types of correlational analyses have also addressed the relationship between 
cognitive and functional capacity variables. McClure and colleagues (2007) examined 
associations between different neuropsychological abilities and performance-based measures of 
social and living skills. Two canonical roots were differentially associated with these aspects of 
functional capacity; processing speed, episodic memory, and executive functions were associated 
with everyday living skills (as measured by the UPSA) while working memory, episodic 
memory, and verbal fluency were associated with social competence (measured by another 
performance-based measure of functional capacity).  
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To date, only two factor analytic studies have been conducted on cognitive and functional 
capacity measures in schizophrenia. The first was a study that examined the longitudinal factor 
structure of these measures and indicated that the two may be determined by a single construct 
(Harvey et al., 2013). Moreover, the group demonstrated that an advantage of 
neuropsychological tests was their higher test-retest reliabilities relative to functional capacity 
measures. The second study looked at the factor structure of traditional neuropsychological and 
functional capacity measures in two studies of patients with schizophrenia and bipolar I disorder 
(Harvey et al., 2016). This study concluded that performance on these measures is best explained 
as a single latent trait in both patient groups. Although the results of these studies are consistent, 
they have notable limitations. First, neither study assessed the full range of cognitive domains 
relevant to community outcome in schizophrenia (as outlined by Nuechterlein et al., 2004). 
Second, the samples in the Harvey and colleagues (2016) study differ from typical patients with 
schizophrenia in that they consisted of either veterans who were older and had a later onset of 
schizophrenia or individuals with Ashkenazi Jewish background who are typically more 
educated than individuals with schizophrenia and the US population as a whole. Thus, the results 
may not generalize to the overall schizophrenia population. Lastly, although choice of statistical 
analyses (e.g., rotation methods) are known to influence the results of factor analysis, these 
authors did not explain several important details of how their analyses were conducted and the 
analyses that were explained are not consistent with best practices (i.e., Costello & Osbourne, 
2005). Nonetheless, this preliminary research suggests that the tendency to consider cognition 
and functional capacity as distinct constructs may be inaccurate. 
If these abilities do represent the same construct, then an important consideration is 
whether capacity measures provide incremental validity over and above cognition measures. 
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However, the literature presents conflicting data on this matter as some studies have reported 
added predictive validity by capacity measures beyond that accounted for by cognitive measures 
(e.g., McDermid Vaz et al., 2013), while others have demonstrated that capacity measures 
contribute very little to no incremental validity (Heinrichs et al., 2010; Heinrichs, Statucka, 
Goldberg, & McDermid Vaz, 2006; Twamley et al., 2002). For example, in a study examining 
the benefit of intact cognitive abilities in schizophrenia, functional capacity measures did not 
provide any predictive validity over and above cognitive functioning (Muharib et al., 2014). 
Moreover, while a group of patients with schizophrenia in this study demonstrated cognitive and 
functional competence equivalent to cognitively average controls and better than that of patients 
with impaired cognition, their community outcome was worse than that of controls and 
equivalent to patients with impaired cognition. It is unclear whether the variability in functional 
capacity measures’ ability to predict community outcome over and above cognitive measures 
reflects differences in the clinical and demographic characteristics of the study samples, 
differences in the instruments used to measure capacity (e.g., item content or difficulty level), or 
if it is a feature of the functional capacity construct itself.  
While functional capacity measures were introduced to provide a more ecologically valid 
proxy of everyday functioning, whether they resolve the problem of capturing more variability in 
community functioning remains controversial. Although some research has focused on clarifying 
the mechanisms by which constructs such as cognition and functional capacity predict outcomes, 
the validity of the constructs in question is seldom evaluated beforehand. Instead, these variables 
are entered into analyses such as confirmatory factor analyses (CFA) as distinct constructs 
without exploration of their own factor structure first (e.g., Bowie et al., 2006, 2008; Strassnig et 
al., 2015). While exploratory factor analysis (EFA) is not a mandatory pre-requisite to CFA, it is 
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highly recommended when the distinctness of the constructs has not been validated; otherwise, 
analyses can lead to inaccurate results.  
Considering the degree of shared variance between cognition and functional capacity 
(e.g., Keefe et al., 2006), examining whether these constructs are distinguishable will allow for 
increased confidence in the interpretation of research findings that draw conclusions about 
community outcome. For example, several lines of research suggest that functional capacity 
mediates the relationship between cognition and community outcome. This finding has treatment 
implications as more proximal measures of community outcome are expected to more directly 
affect functioning in the community and are therefore considered more viable treatment targets. 
Lastly, elucidating the nature of the relationship between functional capacity and cognition will 
provide insight into whether functional capacity measures serve their intended purpose (i.e., 
serve as a distinct but related co-primary measure) and if their use continues to be appropriate in 
predicting community functioning alongside cognition.  
If these abilities are distinguishable and therefore the conclusions of previous studies 
demonstrating that functional capacity mediates the relationship between cognition and 
community outcome are accurate, then treatments targeting functional capacity have the potential 
to be more successful in improving community outcome than those aimed at improving 
cognition. If these variables are not distinct, then use of both in outcome studies would not only 
be inefficient, but would also not meet the FDA requirement for the inclusion of a separate co-
primary measure in intervention trials. Accordingly, a determination would need to be made 
regarding which type of measure is more appropriate, and in which contexts. Clarifying the 
relationship between these constructs will also assist researchers in determining whether new co-
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primary measures need to be considered which may subsequently contribute to improving 
community outcome. 
The Structure of Cognition 
Within the framework of key predictors of community outcome, the factor structure of 
cognition also remains uncertain. This uncertainty becomes particularly relevant when evaluating 
the nature of the relationship between cognition and community functioning as well as when 
evaluating the relation between capacity and cognition. In the absence of treatments reducing 
disability in schizophrenia, the development of pharmacological treatments with the potential to 
impact cognition have become a high priority (Buchanan et al., 2005) and substantial efforts 
have been invested into this initiative. Certain pharmacological agents are expected to have 
circumscribed effects on aspects of cognition (Nuechterlein et al., 2004; Reilly & Sweeney, 
2014), and thus capturing discrete effects is of paramount importance in assessing the 
effectiveness of pharmacological agents and gaining FDA approval. The clinical relevance of 
identifying separable cognitive abilities in schizophrenia highlights the rationale behind the 
development of the Measurement and Treatment Research to Improve Cognition in 
Schizophrenia (MATRICS), Consensus Cognitive Battery (MCCB; Nuechterlein et al., 2008), a 
battery intended to capture cognitive domains that may be impacted by pharmacological 
treatments. This battery was assembled after inspection of the literature by an expert panel 
identified seven consistently impaired cognitive domains in schizophrenia including verbal 
comprehension, processing speed, attention, working memory, verbal and visual memory, and 
reasoning (Nuechterlein et al., 2004); six of these domains were considered appropriate targets 
for pharmacological interventions aimed at improving cognition. The panel also indicated that 
these domains reflect separate abilities; a claim that has important treatment implications.  
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One of the largest studies to explore the claim of separable cognitive abilities was by 
Keefe and colleagues (2006) who used data from the Clinical Antipsychotic Trials of 
Intervention Effectiveness (CATIE) schizophrenia trial. This sample consisted of a 
heterogeneous cohort of 1,493 schizophrenia patients from 48 cities across the United States. 
With the exception of verbal comprehension and visual memory, their selected tests represented 
the same cognitive domains identified by the expert panel. The results of their EFA suggested 
that a one-factor model consisting of five domain scores, as opposed to nine test summary 
scores, best explained the data. Nevertheless, this single factor only accounted for 45% of the 
variance in the data. In contrast to a one-factor solution, an extensive body of literature has 
argued that cognition in schizophrenia is best explained by multi-factor models. However, the 
number of factors identified has varied from as few as two factors (Mohn, Lystad, Ueland, 
Falkum, & Rund, 2017) to as many as six (Gladsjo et al., 2004; Ojeda, Pena, Sanchez, 
Elizagarate, & Ezcurra, 2008), and while studies have used different batteries, even those 
employing similar measures or representing the same cognitive domains have yielded different 
results. For example, a study by Bowie and colleagues (2008) used measures that represented the 
same cognitive domains as Keefe et al. (2006) but determined that a four-factor model best 
explained the data. The four factors included attention/working memory, verbal memory, 
processing speed, and executive functions.  Yet another study examined the factor structure of 
cognitive domains in schizophrenia patients (Burton et al., 2013) but did so using the MCCB. As 
noted, this measure was developed based on the recommendations of the aforementioned expert 
panel. These authors determined that a three-factor model representing processing speed, 
working memory/attention, and memory domains best fit the data. In addition to the lack of 
replicability of results, a key limitation across these studies is that none included measures of 
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verbal comprehension and both the Keefe et al. (2006) and Bowie et al. (2008) studies failed to 
include measures of visual memory. Nonetheless, both of these cognitive domains are considered 
important in this population as they have been found to be consistently impaired in, and 
functionally relevant to, schizophrenia (Heinrichs & Zakzanis, 1999; Nuechterlein et al., 2004). 
Thus, none of the analyses investigating the factor structure of cognition have considered the full 
range of relevant neuropsychological domains.  
Another key limitation of studies examining the factor structure of cognition involves the 
statistical methods used to define latent constructs, in particular the extraction and rotation 
methods. Best practices recommend EFA (e.g., rather than principal components analysis, or 
PCA) for exploration of factor structure and suggest the use of oblique rotations to allow 
correlated latent variables (Costello & Osborne, 2005); however, researchers do not typically 
adhere to these recommendations. In attempting to determine the key separable cognitive 
impairments in schizophrenia, Nuechterlein et al. (2004) reviewed the empirical evidence for 
cognitive domains in schizophrenia, with a particular focus on factor analytic studies. Of the 13 
studies identified by their review, nine had used principal component analysis (PCA) as their 
extraction method. Additionally, Varimax rotation, an orthogonal rotation method, was most 
commonly employed. These statistical methods continued to be applied to the more recent factor 
analytic studies described above which either only used CFA, used PCA, or assessed factor 
structure with EFA but with an orthogonal rotation method. Given that cognitive factors are 
typically moderately correlated (e.g., Keefe et al., 2006; Dickinson & Gold, 2008), use of 
orthogonal rotations is inappropriate. Additionally, although PCA is the most common extraction 
method in the social sciences, it is a data reduction method that does not take into account the 
underlying structure caused by latent variables (Costello & Osborne, 2005). In contrast, in an 
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EFA, the shared variance of a variable is separated from unique variance and error variance to 
establish the underlying factor structure. A limitation of PCA, which does not apply to EFA, is 
that this factor analytic method uses all variances to determine components and can yield 
exaggerated values of variance accounted for by the components.  
These varied and less optimal statistical methods for exploring the factor structure of 
cognition in schizophrenia present another explanation for disparate results and why the factor 
structure of cognition remains unknown; this situation subsequently presents a challenge for 
unpacking predictors of outcomes. Taking this background into account, one of the goals of the 
present study included better understanding the factor structure of cognition by including all 
seven cognitive domains identified by the expert panel and applying best practices for factor 
analysis. 
Community Outcome in Schizophrenia 
 Community outcome in schizophrenia is a complex and a multi-determined construct. 
Essentially, it refers to how an individual functions in their community. Alternate terms of this 
construct include functional outcome, functional disability, functional status, everyday 
functioning, real-world outcome, community functioning, and community independence. 
Researchers have employed these terms with slightly varying operational definitions. In defining 
community outcome, the present study took into account three elements: whether an individual is 
performing roles in various settings (i.e., educational, residential, or occupational), how well they 
perform the role, and what supports they receive to perform the role (Jaeger, Berns, & Czobor, 
2003). To illustrate these elements, consider two individuals who are attending university. On the 
surface, it may seem that this educational milestone is indicative of “good” community 
functioning. However, further inspection reveals that one student is in their first year, is taking a 
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partial course load, attends classes only after receiving prompts from family members, and 
barely passes their courses, while the other is completing their final semester, is self-motivated, 
taking a full course load, and achieves a ‘B’ average; these two individuals are displaying 
varying levels of community outcome. Accordingly, our definition of community outcome not 
only takes into account role position (e.g., in university vs. not in university or first year vs. 
fourth year), but also performance (e.g., ‘D’ average vs. ‘B’ average), and supports for role 
completion. 
Numerous variables have been proposed as predictors of community outcome. Of these, 
cognition, functional capacity, psychopathology, and social cognition have received the most 
research backing. Given that the roles of cognition and functional capacity in community 
functioning have already been explored in this paper, the next sections will review the 
contributions of psychopathology and social cognition to functioning in the community. 
 Psychopathology. Psychopathology in schizophrenia has traditionally been divided into 
two categories: positive symptoms and negative symptoms (Andreasen & Olsen, 1982). Positive 
symptoms refer to symptoms that are in excess of normal functions (e.g., hallucinations, 
delusions, etc.) while negative symptoms refer to an absence or reduction of regular functions 
(e.g., blunted affect, emotional withdrawal, etc.). Additionally, there is a host of other “general” 
or non-psychotic symptoms which individuals with schizophrenia may experience, such as 
anxiety, depression, or somatic concerns, among others. Research has shown that positive, 
negative, and general psychopathology can account for almost half of the outcome variance seen 
in patients with schizophrenia and that symptoms contribute to the prediction of outcomes 
independently of cognition (Heinrichs et al., 2009).  
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While the presence of positive symptoms are a prerequisite for a diagnosis of 
schizophrenia (American Psychiatric Association, 2013) and add unique variance to outcome 
performance (Heinrichs, Ammari, Miles, McDermid Vaz, & Chopov, 2009; Wittorf, 
Wiedemann, Buchkremer, & Klingberg, 2008), negative symptoms are considered more 
predictive of poor community functioning, partly due to findings that improvement in psychotic 
symptoms has limited functional impact (Hegarty, Baldessarini, Tohen, Waternaux, & Godehard, 
1994; Jääskeläinen et al., 2012). Instead, negative symptoms, which are typically more persistent 
throughout the illness course (i.e., visible in chronically and acutely ill patients and during 
periods of positive symptoms remission), are believed to be more closely tied to functioning 
levels (Bozikas et al., 2006; Tamminga, Buchanan, & Gold, 1996).  
The severity of negative symptoms is associated with functioning in the community and 
social behavior (Bozikas et al., 2006; Smith, Hull, Huppert, & Silverstein, 2002). Reduced 
motivation is a key negative symptom that has been identified as contributing to poor community 
outcome. In fact, some researchers have found amotivation to be the most robust predictor of 
community outcome (Fervaha, Foussias, Agid, Remington, 2013; Foussias et al., 2011), 
sometimes with little to no additional predictive validity offered by cognition 
(Konstantakopoulos et al., 2011). This result, however, is at odds with other research which has 
demonstrated an association between cognition and community outcome even after controlling 
for motivation levels (Fervaha, Foussias, Agid, & Remington, 2014; Green, 1996; Green et al., 
2000) and with research showing that cognition and symptoms each independently contribute to 
the prediction of community outcome (Heinrichs et al., 2009). Others report that the severity of 
negative symptoms is related to cognition and community outcome and that negative symptoms 
mediate the relationship between cognition and outcomes (Ventura, Hellemann, Thames, 
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Koellner, & Nuechterlein, 2009). These conflicting reports again highlight the current limited 
understanding of disability and further underscore the need to evaluate how these factors predict 
community outcome in concert. To further complicate matters, yet another variable has been 
claimed to be the most predictive of community outcome: social cognition. 
Social Cognition. Social cognition has been defined as the mental processes that allow 
individuals to “understand, act on, and benefit” from interpersonal interactions (Corrigan & 
Penn, 2001). This construct has recently received a lot of attention in the schizophrenia literature 
as researchers have hypothesized that impairments in social cognition may explain difficulties 
with forming and maintaining interpersonal relationships and subsequently influence 
performance in functional domains such as education, employment, and residential living (Green 
& Horan, 2010; Green, Horan, & Lee, 2015, Mancuso, Horan, Kern, & Green, 2011). 
Social cognition is differentiated from non-social cognition in that it includes social and 
emotional processing while non-social cognition does not. Research has indicated that social 
cognition represents a distinct ability from non-social cognition (Sergi et al., 2007). Social 
cognition has been conceptualized as being composed of four somewhat overlapping skill sets: 
emotional processing, social perception, attribution style, and theory of mind (Green & Horan, 
2010; Green, Olivier, Crawley, Penn, & Silverstein, 2005). Emotional processing refers to the 
ability to perceive affective information from others. Social perception refers to the ability to 
understand social roles and conventions within a social context. Attribution style refers to the 
idiosyncratic inferences of causes of events (i.e., due to others, oneself, or the situation). Lastly, 
theory of mind includes the capacity to both recognize that others have their own mental states 
and the ability to correctly infer the intentions or beliefs of others. Individuals with schizophrenia 
demonstrate impairments in all of these domains (Green & Horan, 2010). Moreover, the 
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magnitude of impairments in these skill sets is large (Salva et al., 2013). A meta-analysis 
revealed that relative to controls, schizophrenia patients performed worse across all domains, 
with standardized mean differences or Hedges’ g = 1.04 for social perception, Hedges’ g = 0.96 
for theory of mind, Hedges’ g = 0.89 for emotion perception, and Hedges’ g =  0.88 for emotion 
processing (Salva, Vella, Armstrong, Penn, & Twamley,  2013); indicating large statistical 
differences between patients and controls across all social cognitive domains. 
Difficulties with social cognition have been shown to add incremental validity to the 
prediction of community functioning beyond that accounted for by non-social cognition and 
symptoms (e.g., Mancuso et al., 2011) and mediate the relationship between cognition and 
community outcome. Sergi, Rassovsky, Nuechterlein, and Green (2006) demonstrated that social 
perception mediates the relationship between early visual processing and functional status. This 
study was a significant contribution to the field as the authors chose a very basic aspect of 
cognition (i.e., early visual processing) which temporally precedes social cognition. This choice 
of measure clarified that social cognition mediates the relationship between cognition and 
community outcome instead of the reverse pattern (i.e., cognition mediating the relationship 
between social cognition and outcome). This distinction is pertinent as it provides a treatment 
target because interventions aimed at reducing disability would need to target aspects of the 
model most closely related to community outcome.  The results of this study are consistent with 
other studies that also demonstrated that social cognition mediates the association between 
cognition and community outcome  (e.g., Addington, Girard, Christensen, & Addington, 2010; 
Gard, Fisher, Garrett, Genevsky, & Vinogradov, 2009; Vauth, Rusch, Wirtz, & Corrigan, 2004). 
Gard and colleagues (2009) devised a study in which they attempted to integrate 
neuropsychological, psychological, and socio-behavioural variables into a model that would 
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explain mediating pathways from social cognition and cognition to community outcome. 
Specifically, they collected cognitive, social cognitive, and negative symptom (motivation) data 
and examined how these variables relate to one another and to community outcome. The results 
of their study indicated that social cognition mediates the relationship between neurocognition 
and functional outcome and that motivation further plays a mediating role in the relationship 
between neurocognition, social cognition, and functional outcome. This study is a significant 
improvement on previous models because it includes aspects of cognition, social cognition, and 
negative symptoms in predicting outcomes. Moreover, it is consistent with current perspectives 
(i.e., Green et al., 2005) that inclusion of cognitive, social cognitive, and psychological variables 
in models may best advance understanding of the causal determinants of functional outcome in 
schizophrenia. However, this study did not include or consider the role that functional capacity 
may play in explaining outcomes. Current research must consider all relevant variables, 
determine whether previous results can be replicated, and assess which models of outcome 
account for the greatest amount of variance in community outcome. 
Current Study 
To review, improving community functioning in schizophrenia continues to be a clinical 
and research challenge. A significant body of literature suggests that cognition is the best 
predictor of community outcome. However, cognition only captures a small fraction of the 
variability in community outcome and improvements in cognition do not necessarily translate to 
improvements in daily functioning. Accordingly, the FDA recommended that a more clinically 
meaningful measure be introduced to capture everyday functioning. The resultant measures, 
which have been conceptualized as reflecting the construct of functional capacity, have gained 
popularity in the outcome literature and have empirical support as mediators of the relationship 
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between cognition and community outcome. However, it is unclear whether these performance-
based measures represent a construct that is truly distinct from cognition. Resolving this issue is 
important because the conclusions of previous analyses that have sought to predict community 
outcome depend on the assumption that these variables are distinct. Without empirical evidence 
of this, resulting conclusions may be incorrect and may be hampering efforts to better understand 
community outcome and reduce disability. Moreover, determination of the factor structure of 
cognitive domains relevant to functioning in schizophrenia also requires evaluation as the 
approval of pharmacological treatments for cognitive impairments are contingent on the 
understanding that these domains are separable and that discrete cognitive changes are capable of 
being differentially assessed by traditional neuropsychological measures. Accordingly, the first 
goal of the present research study is to determine whether cognitive and functional capacity 
abilities represent the same underlying construct. Results of the first part of this study will be 
used to inform the second part of the study which will assess the predictive validity of cognitive, 
social cognitive, symptom, and possibly functional capacity data with respect to community 
outcome. 
Current research in schizophrenia is interested in the mechanisms by which cognition 
accounts for community outcome and the role that functional capacity plays in this relationship. 
An essential first step in unpacking the respective contributions of several predictors of outcomes 
includes understanding what these constructs truly represent. Although cognition and functional 
capacity are theoretically distinct, this assumption has not been validated empirically. The factor 
structure of these constructs has both clinical and methodological implications. Clinically, if 
neuropsychological and capacity instruments measure the same construct, then administration of 
both measures would be redundant and inefficient. Additionally, cognitively enhancing 
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treatments in schizophrenia require evidence of change on both cognitive and a separate co-
primary measure to demonstrate a treatment effect. If these constructs are not distinct, then the 
current use of functional capacity measures would be inappropriate and alternative co-primary 
measures would need to be identified and used instead (Harvey et al., 2013). Methodologically, 
determining whether these constructs are dissociable prior to estimating CFA models will allow 
for more complete interpretations of data. If these constructs are not distinguishable and 
functional capacity may just be a more face valid measure of cognition, as several lines of 
research have suggested, then analyses determining contributors to outcome will need to be 
reconsidered. For example, recent studies which attempted to uncover the relationship between 
capacity, cognition, symptoms, and outcome indicated that capacity mediates the relationship 
between cognition and community outcome (e.g. Bowie et al. 2006; 2008). However, if capacity 
and cognition represent the same construct, then the observed variables (i.e., performance on 
cognition and capacity measures) should comprise one latent variable. Including these observed 
variables as one factor is expected to produce different results than those previously reported.  
Progress cannot be made until there is a clearer understanding of how cognition and functionality 
are related. 
Accordingly, the aim of the present investigation is to evaluate the validity of this dual 
model of cognition and functional capacity in schizophrenia. This will be achieved by 
performing an EFA of cognitive and functional capacity measures in an archival dataset. Unlike 
previous publications, cognitive tests included in this analysis will represent all cognitive 
domains claimed to be separable (Nuechterlein et al., 2004), including: verbal comprehension, 
reasoning, processing speed, attention, verbal memory, visual memory, and working memory. 
While previous factor analytic studies have consistently excluded verbal comprehension because 
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it is considered resilient to change (both neurological and pharmacological), the present study 
will include this ability as it seeks to explore the full range of functionally-relevant cognitive 
domains. The results of the EFA will determine the optimal number of factors underlying these 
variables. The number of factors proposed by these analyses will then be evaluated for model fit 
through CFA and expanded to a larger structural equation model (SEM) to evaluate how well 
they predict community outcome. To ascertain that the results are not a function of the selected 
measures, the analysis will then be repeated on a second archival dataset with different measures 
of cognition and capacity. Thus, both new and less standard measures of functional capacity and 
cognition will be analyzed. 
Hypotheses. It is hypothesized that a four-factor model will emerge, representing verbal 
ability, processing speed, memory, and a single factor influencing working memory and 
attention. Such results would be similar to those found by Burton and colleagues (2013) who 
examined the factor structure of domains contained within the MCCB, but would also include a 
verbal ability factor, a domain not measured in their study. It is further hypothesized that 
measures of functional capacity will not represent a distinct factor but will instead be determined 
by one or more cognitive factors. Statistical support for a model in which cognition and capacity 
load on the same factor(s) would suggest that these constructs represent the same underlying 
latent variable(s) and that their inclusion as distinct predictors in outcome studies has led to 
misleading conclusions. If the same construct underlies cognition and capacity, accepted models 
of community outcome will need to be revisited. 
Elucidating the nature of these constructs is only the first step in clarifying which 
variables predict community outcome and how they combine to do so. Regardless of whether 
cognition and capacity are redundant, the problem of improving community outcome remains. 
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Accordingly, the second part of the current study will use results from the EFA to assess the 
ability of cognition and functional capacity (either as a single factor or two factors), symptoms, 
and social cognition to predict community outcome. Using structural equation modeling, the 
present study will examine the latent variable predictors of community outcome, their relationship 
to one another, and the total amount of variance in outcome that can be predicted by these 
constructs.  
Method 
Dataset One  
Participants. Individuals with schizophrenia or schizoaffective disorder were recruited 
from three outpatient clinics in Hamilton, Ontario: the Cleghorn Early Intervention in Psychosis 
Program, the Hamilton Program for Schizophrenia, and the Community Schizophrenia Service. 
This sample was recruited through flyers posted at these settings and referrals by case workers. 
To participate in the study, patients had to meet several inclusion criteria including: 1) a 
confirmed diagnosis of schizophrenia or schizoaffective disorder by the Structured Clinical 
Interview for DSM-IV Axis I Disorders (SCID-I; First, Spitzer, Gibbon, & Williams, 1996) with 
no concurrent diagnosis of substance use disorders; 2) no history of a developmental or learning 
disability; 3) no history of a neurological or endocrine disorder; and 4) age between 18 and 65 
years. These criteria yielded 100 participants. The demographic and clinical characteristics of 
patients in dataset one are reported in Table 1. 
Measures. Neuropsychological measures assessing cognitive domains relevant to the 
schizophrenia population (as identified by Nuechterlein et al., 2004) were administered to all 
participants. To assess these domains, the MCCB was administered. As mentioned, this battery 
assesses six cognitive ability factors including processing speed, working memory, verbal 
  25 
learning and memory, visual learning and memory, reasoning and problem solving, and 
attention/vigilance. All MCCB cognitive domains were included in the analysis. The social 
cognitive task in the MCCB was not included in the EFA (but was included as a covariate in the 
CFA) because it represents an empirically and neurobiologically distinct ability from non-social 
cognition (Green et al., 2008; Fett et al., 2011). Finally, the Vocabulary subtest of the Wechsler 
Abbreviated Scale of Intelligence (WASI; Psychological Corporation, 1999) was used as a 
measure of verbal comprehension. 
The Multidimensional Scale of Independent Functioning (MSIF; Jaeger et al., 2003) is a 
measure of “real-world” or community outcome in mental health outpatients. It was designed to 
address the shortcomings of other community outcome instruments such as their limited ability 
to assess disability in major life roles as well as changes over time in adaptive behaviour, overall 
functioning, and activities of daily living. The MSIF assesses functioning in three domains 
across three environments: assessments are made of an individual’s expected role responsibility 
(i.e., role position), support received for that role (i.e., support), and quality of productive 
activities (i.e., performance) across work, educational, and residential settings. Ratings for each 
dimension in each of these three settings are made along a 7-point Likert-type scale, with lower 
scores reflecting better functioning. Detailed anchors are provided to increase reliability by 
providing common reference points for interviewers (Jaeger et al., 2003). 
As noted, the COALS (McDermid Vaz et al., 2013) is a performance-based measure of 
capacity to perform everyday functioning. This measure assesses five functional domains 
relevant to independence in the community: health and hygiene, time management, 
transportation, crisis management, and domestic activities.  Participants are instructed to either 
roleplay or respond to situations considered important for independent living (e.g., which bus 
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route to take to arrive at an appointment on time or how to prepare a nutritious meal for dinner). 
Participants are scored on each of the five domains with summary scores reflecting procedural 
knowledge routines, or the knowledge of how to perform an activity important for independent 
living, and executive operations, or the planning, problem solving, and execution of a plan. For 
example, in attempting to carry out an adaptive activity such as preparing a meal, one may need 
to read a recipe, follow instructions, and carry out the motor movements required; these basic 
cognitive and behavioral skills are referred to as procedural knowledge routines within the 
COALS. An individual would also need to plan, problem solve, and execute plans for preparing 
dinner, such as determining whether the needed ingredients are on hand and what to do if not, 
and deciding how to adjust plans in the event of unexpected circumstances, such as guests 
arriving for dinner. These skills are referred to as executive operations within the COALS. While 
a total score can also be calculated, the executive operations score has been shown to provide 
incremental validity in community outcome over and above the procedural knowledge routines 
score alone (McDermid Vaz et al., 2013). Given that the overarching goal in the literature is 
identifying key elements of predictors of community outcome, the COALS executive operations 
and procedural were included as separate scores. 
The UPSA (Patterson et al., 2001) was administered to assess functional capacity. This 
performance-based measure assesses skills in five areas: ability to perform household chores, 
communicate, manage money and finances, use public transportation, and plan recreational 
activities. Scores across these skills are then summed for a total score. 
Procedure. Patients participated in three assessment sessions at two time points each. 
During the first session, patients provided written informed consent and communicated their 
social and psychiatric history. Afterwards, the SCID-I/P was administered to confirm a diagnosis 
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of either schizophrenia or schizoaffective disorder and the Positive and Negative Syndrome 
Scale (PANSS; Opler, Kay, Lindenmayer, & Fiszbein, 1999), a semi-structured interview 
assessing symptom severity, was administered. The WASI and MCCB were administered during 
the second assessment session and the MSIF, COALS, and UPSA were administered during the 
third. Finally, there were three follow-up sessions, approximately three months later, which were 
structured in the same manner and collected the same variables. All participants were thanked for 
their time and were compensated $20 for each session. 
Dataset Two 
Participants. Data were also obtained from a second archival dataset. This sample 
consisted of 157 participants with a DSM-IV confirmed diagnosis of schizophrenia or 
schizoaffective disorder.  Recruitment strategies, exclusion criteria, and data gathering procedures 
were similar to the first study; however, the specific measures administered differed. Follow-up 
for this sample occurred 12 months after the initial set of assessments. The demographic and 
clinical characteristics of patients in dataset two are reported in Table 1 and educational 
achievement for this sample is reported in Figure 1. 
Measures. Cognitive abilities in the second dataset were measured using the Wechsler 
Adult Intelligence Scale III (WAIS-III; Wechsler, 1997), Conners’ Continuous Performance Test-
II (CPT-II; Conners, 2000), and the California Verbal Learning Test-II (CVLT-II; Delis, Kramer, 
Kaplan, & Ober, 2000). Specifically, the WAIS-III assessed verbal ability via the Vocabulary 
subtest, reasoning with the Matrix Reasoning subtest, working memory with the Letter-Number 
Sequencing subtest, and processing speed was measured with the Symbol Search subtest. 
Additionally, CPT-II measured sustained attention and the CVLT-II measured verbal learning and 
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memory. As in the first dataset, the UPSA assessed functional capacity and the MSIF was used for 
assessment of community outcome. Table 2 lists the measures used in each dataset. 
Data Analysis 
The analysis was carried out in two phases. The first part of the analysis included an EFA 
of the cognitive and capacity measures in datasets one and two to empirically identify the 
underlying factors required to complete cognitive and functional capacity tasks and determine 
whether separate factors are needed to represent cognitive and functional capacity tasks. First, 
correlation matrices and multivariate distributions were examined for each dataset. 
Transformations were applied as needed. Next, an EFA of the cognitive and functional capacity 
subscales assessed underlying common factors. Given that cognitive processes correlate 
substantially (Dickinson & Gold, 2008) and function as part of interconnected neural networks, an 
oblimin rotation was applied to reflect naturalistic processes and increase ecological validity. 
Additionally, best practices in EFA recommend use of oblique rotations as applying orthogonal 
rotations to factors that are strongly correlated results in the loss of valuable information (Costello 
& Osborne, 2005). Parallel analysis, factor loadings, communalities, residual correlation matrices, 
and root mean square residual values were inspected and informed the number of factors that best 
explained the data. The second part of the study evaluated how well the selected factor solutions 
predicted community outcome. These models were specified using structural equation modeling 
and, more specifically, CFA. The results of the EFA were used to inform the second part of the 
study by defining how variables were grouped into factors. Finally, the accepted models, along 
with other key predictors of outcomes (e.g., social cognition, symptoms) were evaluated for their 
ability to explain the variance in community outcome. 
Exploratory Factor Analysis of Dataset One  
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Indicators of cognition in the first dataset included T-scores of the selected MCCB and 
WASI cognitive tests. Given that a goal of EFA is to determine how cognitive tests load on 
separate factors, individual MCCB tests were used instead of domain scores which are already 
aggregated. While use of domain scores in similar analyses is common in the literature, using 
domain scores restricts test scores to a preconceived notion of how the tests ought to relate to 
domains rather than empirically establishing underlying latent abilities. An added benefit of using 
performance on cognitive tests as opposed to pre-specified MCCB domains is the potential for 
better comparisons across studies in the literature including those which do and do not use the 
MCCB. The specific MCCB subtests included in the current study were: Category Fluency 
(animals), Brief Assessment of Schizophrenia Symbol Coding (BACS), Brief Visual Memory 
Test-Revised (BVMT-R), Hopkins Verbal Learning Test-Revised (HVLT-R), Letter-Number 
Sequencing (LNS), Neuropsychological Assessment Battery Mazes (Mazes), Spatial Span, Trail 
Making Test-Part A (TMT), and Continuous Performance Test – Identical Pairs (CPT-IP). As per 
Kern and colleagues (2011), these tests are purported to represent the following cognitive 
domains: processing speed, working memory, verbal learning and memory, visual learning and 
memory, reasoning, and attention (see Table 1). The Vocabulary subtest of the WASI was 
included as an indicator of verbal ability. Indicators of functional capacity included the UPSA 
total score and the procedural knowledge and executive operations summary scores of the 
COALS. Indicators of community outcome included MSIF role position, MSIF performance, and 
MSIF support scores. 
Exploratory Factor Analysis of Dataset Two 
The same statistical analyses were repeated using a second dataset with different 
measures. Indicators of cognition in the second dataset included T-scores from the following 
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WAIS-III subtests: Vocabulary, Matrix Reasoning, Letter-Number Sequencing (LNS), and 
Symbol Search subtests which represented verbal ability, reasoning, working memory, and 
processing speed domains, respectively. Category Fluency (animals) raw scores also represented 
processing speed,, the CPT-II d’ T-scores were included as a measure of attention, and the CVLT-
II total recall T-score represented verbal memory. Indicators of functional capacity included the 
UPSA summary score and indicators of community outcome included MSIF role position, MSIF 
performance, and MSIF support scores. 
Structural Equation Modeling of Dataset One and Dataset Two 
The results of the EFA for dataset one and two were used to inform which variables 
represented the identified factors. These models were then evaluated through CFA and SEM. The 
main purpose of the CFA was to represent a measurement model for cognition and functional 
capacity which could then be expanded to a larger SEM to evaluate how well these variables 
(either as a single or multiple factors) predict a community outcome factor. Several fit statistics 
were used to characterize model fit. The Comparative fit index (CFI) and Tucker-Lewis index 
(TLI) are reported; values closer to 1.0 (i.e., .9 and greater) are indicative of good fit. Root-Mean 
Squared Error of Approximation (RMSEA) and Standardized Root Mean Square Residual 
(SRMR) are reported, with values less than .08 indicating adequate fit. Determination of model fit 
was made by considering all fit statistics in concert.  
Results 
  Exploratory Factor Analysis of Dataset One 
Data on 13 variables across 100 patients with schizophrenia or schizoaffective disorder 
were first inspected for missing values. Four data points were missing, which accounted for less 
than 5% of the sample. Accordingly, listwise deletion reduced the sample size to n = 96. 
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Linearity of bivariate associations was assessed with pairwise scatterplots. While the bivariate 
relationships between most of the variables were approximately linear, relationships between 
most variables and the CPT-IP and LNS variables were non-linear. Accordingly, these variables 
were transformed with a natural logarithm function. Bivariate relationships were overall linear 
after these transformations were applied. 
Next, a sample correlation matrix was computed to examine the bivariate relations 
between observed variables; see Table 3. Most of the correlations were low to moderate with the 
exception of a strong correlation between COALS procedural knowledge and COALS executive 
operations (r = .74), COALS procedural knowledge and UPSA (r = .66), and COALS executive 
operations and UPSA (r = .63). Additionally, there were several very weak correlations among 
cognitive measures (r = .04 to r = .14). The overall range of correlations indicated that there may 
be one or more common latent variables which explain performance across cognitive and 
functional capacity measures. Parallel analysis (Figure 2) suggested that a two-factor model may 
best explain the data. 
An EFA, estimated using unweighted least squares, was conducted on the ten cognitive 
measures and three functional capacity indices to uncover the common factors that explain the 
pattern of relationships among the observed variables. Based on the sample correlation matrix, 
parallel analysis, theory, and hypothesis, one-factor, two-factor, three-factor, and four-factor 
models were estimated. An oblimin rotation was applied to multi-factor solutions. Several 
criteria were considered for selecting the model that best fit the data, including the root mean 
squared residual (RMR), communalities, residual correlations, and conceptual interpretations of 
the factors. The RMR for each of the solutions, communalities, residual correlations, and inter-
factor correlations are presented in Tables 4 through 14. 
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The two-factor solution was selected as the optimal model due to clear conceptual 
interpretation of the factors, low RMR (RMR = .05; see Table 4 for RMR comparisons), 
moderate to high communalities (see Table 5), and low residual correlations (Table 6). In the 
two-factor solution, variables that loaded highly (i.e., .45 or greater) on the first factor appeared 
to reflect general cognitive abilities while the second factor appeared to represent visual 
processing speed and attention. The inter-factor correlation between factor 1 and factor 2 was r = 
.46. Several variables had moderate cross-loadings (i.e., between .35 and .45) on both factors 
(i.e., BACS and BVMT-R), which was consistent with the conceptual understanding of the 
factors and processes involved in the tasks.  The other EFA models were rejected for several 
reasons, as outlined below. 
Conceptually, a one-factor model would reflect generalized cognition. This solution was 
rejected due to poor RMR (RMR = .09) and low communalities. Additionally, the model did not 
account for several bivariate relationships (i.e., residual correlations greater than the absolute 
value of .10). Consequently, this model was rejected.  
A three-factor solution was estimated to assess whether fit statistics might improve 
relative to the two-factor solution. Overall, only marginal improvements were observed in 
communalities, residual correlations, and RMR (RMR = .04). In the three-factor model, the 
pattern of factor loadings suggested that factor 1 represented functional capacity abilities and, as 
in the two-factor model, the two remaining factors appeared to represent visual processing and 
attention (factor 2), and a range of cognitive skills related to verbal processes (factor 3). Inter-
factor correlations are presented in Table 11 and ranged from r = .2 to r = .58. The three-factor 
solution did not represent a substantial improvement over the two-factor solution and thus was 
rejected. 
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Given that a four-factor model was hypothesized, this model was also estimated. 
Interpretation of the pattern of factor loadings suggested that factor 1 reflected functional 
capacity, factor 2 represented processing speed abilities, factor 3 reflected verbal output, and 
factor 4 represented learning and working memory domains. Again, fit statistics did not 
substantially improve over a two-factor model (see Tables 12 to 14) and this solution was 
ultimately rejected. The two-factor solution was accepted as the model that best explained the 
data (see Table 5).  
Exploratory Factor Analysis of Dataset Two 
Data on eight variables across 157 patients with schizophrenia or schizoaffective disorder 
were first inspected for missing values and linear bivariate associations. Data were missing for 
two participants, accordingly these cases were removed through listwise deletion. Linearity was 
assessed with pairwise scatterplots; the bivariate relationships between variables were all 
approximately linear. Next, a sample correlation matrix was computed to examine the bivariate 
relations among observed variables (Table 15). Most correlations were low to moderate (e.g., r = 
.22 to r = .59) except for very weak correlations between CPT-II and all variables (r = -.17 to r = 
.06). The overall range of correlations indicated that there may be one or more common latent 
variables which explain performance across cognitive and functional capacity measures. Next, 
parallel analysis (Figure 3) indicated that a model with two factors best explained the data. 
Accordingly, a two-factor solution was estimated first. One-factor and three-factor solutions 
were also estimated. An EFA, estimated using unweighted least squares was conducted on the 
cognitive measures and functional capacity indices to uncover the underlying common factors. 
Oblimin rotations were applied to multi-factor solutions. Ultimately, the two-factor solution was 
accepted as the model that best explained the data.  
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The root mean squared residual for the two-factor solution was low (RMR = .04; see 
Table 16 for comparisons to other solutions) and factor loadings and communalities were 
moderate to high; see Table 17. Conceptually, variables that had higher loadings on the first 
factor reflected general cognitive abilities while those that loaded higher on factor two reflected 
processing speed. The CPT-II variable did not load highly on either factor. The communalities 
indicated that, with the exception of CPT-II, all variables were well-explained by the model. The 
correlation between factors 1 and 2 was strong, r = .66, and most bivariate relationships were 
well-explained by the model; see Table 18. 
 Overall, the two-factor model adequately explained the model. The root mean squared 
residual was in an acceptable range and the bivariate relationships among the variables were 
well-explained by the model. However, the communality for CPT-II was very low. Accordingly, 
a three-factor model was estimated. A one-factor model was estimated to assess the hypothesis 
that cognition and functional capacity measures are indices of one construct.  
Conceptually, the one factor solution would reflect generalized cognition. The RMR for a 
one-factor model was adequate (RMR = 0.06). However, relative to a two-factor solution, 
several of the communalities were lower in this solution, including that of CPT-II; see Table 19. 
The residual correlation matrix for this solution revealed that several bi-variate relationships 
were more poorly explained by the one-factor model than the two-factor model; see Table 20. 
Overall, a one-factor solution was not an adequate representation of the data. A three-factor 
model was estimated to determine whether more factors would better explain the variance in 
CPT-II. However, the three-factor solution included a Heywood case (i.e., indicating the 
presence of a variable with a negative error variance estimate) that rendered the solution invalid. 
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As such, a four-factor solution was not interpreted. The two-factor solution was accepted as the 
model that best explained the data.  
Structural Equation Modeling of Dataset One 
Follow-up data used in the structural equation modeling analysis was collected 3 months 
after the data used for the EFA. This sample consisted of 95 of the original 100 patients; five 
patients were lost due to attrition. Confirmatory factor analysis was first performed to evaluate 
the measurement model of the accepted two-factor solution. Table 21 presents the accepted two-
factor solution and indicates the measures that represented each factor. Note that tasks with 
factor loadings greater than .30 on more than one factor were allowed to freely cross-load in the 
CFA model. Fit statistics, corrected for multivariate non-normality, indicated only marginally 
acceptable model fit, CFI = .91, TLI = .88, RMSEA = .10, SRMR = .07, but were an 
improvement over the fit statistics for the one-factor and three-factor models. 
Next, a structural regression model was estimated to evaluate the ability of these two 
factors to predict the latent variable community outcome, CFI = .91, TLI = .89, RMSEA = .08, 
SRMR = .07. Note that higher scores on the community outcome measure indicate greater 
dependency and poorer outcomes. There was a significant negative association between factor 1 
(generalized cognition) and community outcome, standardized ˆ  = -.47, z = -2.17, p < .05, such 
that, holding factor 2 constant, community outcome is expected to improve by .47 of a standard 
deviation for every one standard deviation increase in generalized cognition. The association 
between factor 2 (visual processing speed and attention) and community outcome was very small 
and non-significant, standardized ˆ  = -.01, z = -0.03, p = .98. Covariates were added to the 
model one at a time due to a limited sample size. Notably, after adding education as a covariate, 
the association between factor 1 and community outcome became non-significant, 
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standardized ˆ  = -.36, z = -1.62, p = .11. The association between education and community 
outcome was significant, standardized ˆ  = -.24, z = -2.19, p < .05, indicating that greater years 
of education were associated with better community outcome. The association between negative 
symptoms and community outcome was also significant, standardized ˆ  = .36, z = 2.55, p < .05, 
such that experiencing greater negative symptoms was associated with poorer community 
outcome. However, when added to the model with education, this association was no longer 
significant and led all other variables to also be non-significant; accordingly negative symptoms 
were left out of the final model. Likewise, the association between community outcome and 
general symptoms was initially significant, standardized ˆ  = .28, z = 2.24, p < .05, however 
when added to the model with education, it was no longer significant and led all other variables 
to be non-significant, and thus was left out of the final model. The associations between 
community outcome and social cognition and positive symptoms were all non-significant in this 
model, all ps > .05. Taken together, factors 1 and 2 accounted for 23% of the variance in 
community outcome (i.e., R2 = .23). After adding education, the model accounted for 28 of the 
variance in community outcome. The final model is presented in Figure 4; correlations between 
exogenous variables are presented in Table 22. 
Structural Equation Modeling of Dataset Two 
Data for this analysis was collected during follow-up sessions 12 months after the data 
collected for the EFA of dataset two. This sample consisted of 128 of the original 157 patients in 
this sample; 27 patients were lost due to attrition. Confirmatory factor analysis was first 
performed to evaluate the fit of the accepted two-factor solution; however, this model did not 
converge. The estimated correlation between factor 1 and factor 2 was 1.015, which is illegal and 
suggests that factors 1 and 2 should not be separate factors. Accordingly, the two factors were 
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combined into a generalized cognition factor and CFA was used to evaluate the one-factor 
solution. Robust fit statistics were very good for this solution, CFI = .97, TLI = .96, RMSEA = 
.06, SRMR = .04. 
Next, a structural regression model was estimated to evaluate the ability of this 
generalized cognition factor to predict the same community outcome latent variable specified in 
the SEM of dataset one, CFI = .93, TLI = .91, RMSEA = .08, SRMR = .06. As noted earlier, 
greater values on the community outcome measure indicated poorer functioning in the 
community. There was a significant negative association between the generalized cognition 
factor and community outcome, standardized ˆ  = -.66, z = -4.44, p < .001, such that outcome is 
expected to improve by .66 of a standard deviation for every one standard deviation increase in 
generalized cognition. After adding negative, positive, and general symptoms as well as 
education as covariates, the association between generalized cognition and community outcome 
remained significant, standardized ˆ  = -.73, z = -4.66, p < .001. The association between 
negative symptoms and community outcome was significant, standardized ˆ  = -.35, z = -2.84, p 
< .01, as was the relationship between general symptoms and community outcome, 
standardized ˆ  = .34, z = 2.46, p < .05. The associations between education and community 
outcome and between positive symptoms and community outcome were not significant, all ps < 
.05. The generalized cognition factor accounted for 44% of the variance in community outcome 
(i.e., R2 = .44). After adding education, positive, negative, and general symptoms as covariates, 
the overall explained variance in community outcome increased to 52%. The final model for 
Dataset Two is presented in Figure 5; see Table 23 for correlations between exogenous variables. 
Discussion 
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The current study demonstrated that cognitive performance and functional capacity are 
indistinguishable. This finding is consistent with a large body of research demonstrating 
convergent validity of these instruments (e.g., Harvey et al., 2013, 2016; Leifker et al., 2011; 
McClure et al., 2007; Pietrzak et al., 2009) and challenges the widespread use and reporting of 
these measures as distinct constructs (e.g., Bowie et al., 2006, 2008; Strassnig et al., 2015). As 
noted earlier, the FDA has required that the efficacy of cognitively-enhancing intervention trials 
be demonstrated on a cognitive battery and a separate co-primary outcome measure (Buchanan et 
al., 2005). In light of research demonstrating no added incremental validity of functional capacity 
measures over cognitive measures in predicting community outcome (e.g., Heinrichs et al., 2006; 
Heinrichs et al., 2010; Muharib et al., 2014; Twamely et al., 2002), the current results do not 
support the use of both types of instruments as outcome measures in treatment evaluation studies.  
Instead, the results suggest the use of either functional capacity or cognitive tests as measures of 
clinical benefit in such studies. Moreover, the results warrant a search for a new co-primary 
measure. Such a measure should comply with the original guidelines which state that co-primary 
measures should be proxy measures of community outcome and be directly associated with (but 
distinct from) cognition and associated with social and occupational functioning (Buchanan et al., 
2005). Measures which have the potential to meet these guidelines include variables that mediate 
the relationship between cognition and community outcome, such as skill acquisition abilities and 
social cognition. 
The identification of a co-primary measure of functional improvement was previously 
identified as one of the most difficult agenda items by experts who sought to provide guidelines 
for clinical trial designs in this field (Buchanan et al., 2005) and remains a major obstacle for the 
development and evaluation of effective treatments. A consensus regarding a co-primary measure 
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would allow for greater cross-study comparisons and would ultimately pave a more efficient path 
to understanding community outcome. Previously, the lack of consensus regarding how to 
measure outcome in cognitively-enhancing drug trials was highlighted as a barrier to their 
development and fueled the MATRICS initiative (Marder & Fenton, 2004). One outcome of this 
initiative was the development of a cognitive consensus battery for measuring treatment efficacy 
(i.e., the MCCB). Similarly, there is now a need for an agreement in the field regarding a co-
primary measure in intervention studies. As noted, previously utilized functional capacity 
instruments are not appropriate for use as separate co-primary outcome measures. The 
development of a consensus of an alternate co-primary measure is a high priority due to its 
treatment implications. 
Given that traditional cognitive and functional capacity instruments measure the same 
underlying abilities, experts in the field may contemplate using functional capacity measures in 
treatment evaluation studies instead of cognitive measures. Indeed, an advantage of using 
functional capacity measures includes their greater face validity and briefer length of 
administration relative to traditional neuropsychological measures. More specifically, 
administration of the MCCB ranges from 60 to 90 minutes whereas the full version of the UPSA 
takes approximately 45 minutes and the more newly developed UPSA-Brief takes 10 to 15 
minutes to administer (Mausbach, Harvey, Goldman, Jeste, & Patterson, 2007). Additionally, 
functional capacity measures are easier to administer as they have fewer standardization rules 
around the pacing of trials, examiner responses for rule violations and errors, as well as start and 
discontinue rules. Accordingly, administration is less prone to administrator errors and thus such 
measures can more easily be administered by individuals who do not have specialized training in 
psychometric administration. However, traditional neuropsychological tests have decades of 
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research supporting their development, refinement, and psychometric properties. While the 
administration of such measures is typically more time and training intensive than functional 
capacity measures, they are nonetheless well-tolerated by patients and also demonstrate minimal 
practice effects (Keefe et al., 2011). As noted by Marder and Fenton (2004), the determination of 
measures for the evaluation of efficacy in treatment trials should be based on a consensus that is 
grounded in robust scientific evidence rather than accepted due to convenience. A significant 
advantage of the MCCB is that tasks included in this battery have greater test-retest reliability than 
functional capacity measures (Harvey et al., 2013; Keefe et al., 2011). Notably, test-retest 
reliability has been deemed the most important property in the selection of measures for 
randomized clinical trials (Buchanan et al., 2005; Green et al., 2004b). Additionally, not only is 
performance on neuropsychological measures associated with community outcome, but 
performance on specific cognitive domains have the added value of differentially predicting 
performance in important life domains. Overall, the advantages of the MCCB outweigh the 
conveniences offered by functional capacity measures and support its designation as a primary 
outcome measure in cognitively-enhancing drug trials. 
The current study was the first to examine the factor structure of all seven cognitive 
domains identified by the NIMH MATRICS expert panel (i.e., Nuechterlein et al., 2004) and it is 
the first to apply best practices to an exploratory factor analysis (see Costello & Osborne, 2005) in 
uncovering the factor structure of cognition in schizophrenia. Although the results of the analyses 
of dataset one and two differ slightly, they demonstrate that the seven cognitive domains identified 
by the expert committee are not separable into seven latent constructs. Numerous research studies 
have also demonstrated that the domains are not separable into seven constructs however they 
have varied in the number of constructs identified (e.g., Burton et al., 2006; Keefe et al., 2006; 
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Mohn et al., 2017). The results of the current study are most suggestive of a generalized model of 
cognition in schizophrenia and are most consistent with the findings of the CATIE trial (Keefe et 
al., 2006), which, despite using differing statistical methods and cognitive tests than the present 
study, concluded that a unidimensional model of cognition best explains cognitive abilities in 
schizophrenia. The matter of separable cognitive abilities is clinically relevant in the context of 
treatment studies. Indeed, one of the main objectives fueling the NIMH MATRICS initiative was 
the identification of cognitive domains that would be amenable to changes via pharmaceutical 
agents and the development of a cognitive consensus battery that could capture these changes. The 
resultant battery, the MCCB, was intended to identify separable cognitive abilities so that domain-
specific treatment effects could be discerned. However, the current results suggest that both the 
MCCB and other batteries assess one generalized ability and are therefore unlikely to detect 
discrete changes that may be caused by pharmacological interventions. Given that mental 
activities rely on a complex interplay of cognitive functions and that even highly developed 
neuropsychological tests require input from many cognitive processes, these results are believed to 
reflect how cognitive functions naturally operate. Rather than viewing the limitations of extant 
cognitive measures as barriers to the development of effective treatments, some have proposed 
that results demonstrating a single generalized cognition factor suggest that pharmacological 
interventions are unlikely to have discrete effects on neural substrates (as reviewed in Dickinson 
& Gold, 2008). While advances from the cognitive neurosciences have better isolated discrete 
cognitive processes, they are more limited in their ability to explain functioning in the community 
than traditional neuropsychological tasks (Reilly & Sweeney, 2014). The current results question 
whether attempting to disaggregate cognitive abilities truly benefits initiatives to develop and 
approve cognitively enhancing treatments. Indeed, the argument that generalized, or broad, 
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cognitive impairment is the most substantial and reliable cognitive signal in schizophrenia has 
been made frequently over the last four decades (Gold & Dickinson, 2013). 
The current study found that almost half of the variance in community outcome can be 
predicted by cognition. This proportion of variance is consistent with several other studies (e.g., 
Keefe et al., 2006; Velligan et al., 1997) and provides additional support for cognition as a key 
predictor of outcomes. However, while cognition in one dataset predicted as much as 44% of 
variance in community outcome, the other dataset only predicted 23% of the outcome variability. 
Others have also noted a wide range of explained variance in community outcome from cognition, 
ranging from as little as 20% to as much as 60%. These results indicate that cognitive measures 
are not equivalent in their ability to predict community outcome. An unexpected finding of this 
study was that a battery of neuropsychological tests, representing the same cognitive domains as 
those in the MCCB, accounted for approximately 20% more variance in community outcome than 
the consensus battery. This finding was surprising because evidence of cognitive tasks’ association 
with community outcome was a key and essential criterion for inclusion in the MCCB. However, 
review of the strength of the relationships between tests retained in the battery and community 
outcome revealed that these associations were moderate at best (Nuechterlein et al., 2008). 
Although the expert committee reviewed over 90 tests, none were rated as being strongly related 
to community outcome. Additionally, other factors, such as test-retest reliability and patients’ 
ability to tolerate tasks, were factored into decisions around test retention. These results may 
explain why the MCCB accounted for less variance in community outcome than an alternate 
battery of neuropsychological tests. 
These results also raise the question of what the optimal range of cognitive assessment in 
treatment studies should be. Indeed, numerous studies have suggested that performance on a 
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limited battery of neuropsychological measures can account for the overall impairment in 
cognitive functioning (Keefe et al., 2006). While generalized impairment is a consistent finding in 
the literature (Gold & Dickinson, 2013), some cognitive domains provide unique exploratory 
power (Green, Horan, & Sugar, 2013). More specifically, there is a differential deficit in verbal 
memory and processing speed even in the context of a generalized cognitive deficit (Dickinson, 
Ragland, Gold, & Gur, 2008) and deficits in these domains are disproportionately larger than that 
of others (Dickinson, Bellack, & Gold, 2007; Heinrichs & Zakzanis, 1998). Consideration of 
differential deficits is important in the context of understanding community outcome as 
performance on tasks assessing these domains are expected to be more strongly related to 
community outcome. Ideally, selection of cognitive assessment measures should consider which 
tests minimize shared variance and thereby provide unique variance. 
While the amount of variance predicted by the database that did not use the MCCB is 
remarkably consistent with that predicted by other models (e.g., Keefe et al., 2006; Velligan et al., 
1997), approximately half of the variance in community outcome remained unexplained, even 
after the addition of social cognition, symptoms, and education as covariates. These results 
underscore the ongoing challenge of explaining the variance in community functioning and 
subsequently reducing functional disability in schizophrenia. While not typically assessed, levels 
of psychosocial supports and services, environmental factors, and opportunities for skill utilization 
are also expected to predict community functioning (Buchanan et al., 2005; Gupta, Bassett, Iftene 
& Bowie, 2012). Two other variables that are expected to impact community outcome include the 
social cognitive domains assessed (Fett et al., 2011; Mancuso et al., 2011) and the specific 
community outcome measures used (Leifker et al., 2011). 
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A notable limitation of the current study was that social cognition was represented in only 
one dataset. Moreover, only one aspect of social cognition was assessed (i.e., emotional 
intelligence) and thereby the full scope of social cognitive domains was underrepresented. While 
the study of social cognition in schizophrenia has a relatively shorter history compared to the 
assessment of non-social cognition, its association with community outcome has been deemed by 
some to be even more strongly related to community outcome than cognition and explain unique 
variance not captured by cognition (e.g., Fett et al., 2011). The omission of a broad assessment of 
social cognition may have substantially reduced the overall explained variance in community 
outcome in this study. Thus, future studies should not only seek to examine the relative 
contribution of social cognition in predicting community outcome, but should also include tasks 
which represent all four domains of social cognition (i.e., emotion processing, social perception, 
attribution bias, and theory of mind; Green & Horan, 2010).  
An additional limitation of the current study is that the assessment of community 
outcome was based on one self-report measure. Notably, substantial discrepancies between self-
reported functioning and informant reports have been demonstrated in the literature and the lowest 
correlations between community functioning and cognitive measures are found in studies 
employing only self-report outcome measures (Leifker et al., 2011). While the MSIF encourages 
the collection of data from informants such as clinicians and family members, doing so is not 
possible for all patients due to limited availability and resources of these informants. Nonetheless, 
an “entirely effective” measure of community outcome in schizophrenia has not been determined 
and, compared to other measures of community outcome, the MSIF is rated highly on reliability, 
convergence with cognitive and functional capacity measures, comprehensiveness, and practicality 
(Leifker et al., 2011).  
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Another limitation of the current study included the non-independence between patients 
included in the EFA analysis and those in the CFA analysis. Ideally, CFA analyses should not be 
conducted on the same data from which the factor structure was determined. In the case of both 
datasets in this study, the CFA was conducted on data collected at a second time-point which 
consisted of a large subset of participants who participated in the first data collection time-point. 
Thus, while participants were not independent, the analyses were not performed on the same data. 
An additional limitation was that cognitive data used in the study was not corrected for education. 
While education-corrected T-scores were available for the MCCB, this was not the case for other 
cognitive measures (e.g., WAIS-III, UPSA, COALS). Although this limitation was partially 
remedied by including education as a covariate, education is known to have a differential impact 
on cognitive tasks (e.g., has a greater influence on verbal knowledge and IQ than on some other 
abilities) and is also known to interact with age and gender (Brooks, Sherman, Iverson, Slick, & 
Strauss, 2011). Accordingly, use of education-corrected T-scores has the potential to generate 
different results. Given that the MCCB is recognized as a gold standard for measuring cognition in 
schizophrenia, this is unlikely to be an on-going limitation in future studies employing cognitive 
measures, however, the impact of demographic variables on performance on social cognitive and 
functional capacity measures will need to be determined and factored into future studies. 
Conclusions 
Understanding predictors of community outcome in schizophrenia continues to be a 
research and clinical challenge. Significant efforts have been invested into understanding and 
reducing functional disability in this population. One such initiative included the introduction of 
the concept of functional capacity, which was intended to serve as a proxy measure of functioning 
in the community and serve as a distinct co-primary measure alongside traditional 
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neuropsychological tests (Buchanan et al., 2005). The purpose of this study was to assess whether 
the conceptualization of cognition and functional capacity as separate constructs is empirically 
supported. The results do not support this bifurcation and instead suggest that functional capacity 
tasks may be better understood as variants of standard cognitive measures that incorporate more 
ecologically meaningful stimulus material and performance requirements, but without evidence 
that this incorporation increases ecological validity. These results indicate that the use of 
functional capacity instruments as co-primary measures alongside neuropsychological tests is not 
warranted as these measures are largely redundant with one another. Consequently, alternative 
measures that are directly associated with cognition and community functioning will need to be 
reviewed for the purpose of determining a new co-primary measure. A consensus around an 
appropriate co-primary measure is expected to support the development of treatments aimed at 
improving cognition, and thereby community outcome, in schizophrenia. Researchers are also 
encouraged to carefully consider which cognitive tasks are included in future studies. While it is 
expected that differing batteries will assess a single construct of generalized cognition, they will 
vary in their ability to explain variance in community outcome. Lastly, the field will benefit from 
ongoing investigations into undiscovered predictors of community outcome to ultimately reduce 
the functional disability which individuals with schizophrenia endure. 
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Table 1 
Demographic Variables of Dataset One and Dataset Two 
Demographic Variable 
Dataset One 
(n = 100) 
Dataset Two 
(n = 157) 
Age (years), mean (SD) 41.66 (10.27) 40.98 (9.31) 
Sex, n male (%) 78 (78%) 99 (63%) 
Education (years), mean (SD) 13.02 (2.34) - 
First Language, n English (%) 87 (87%) 129 (82%) 
Premorbid IQ* (standard score), mean (SD) 97.47 (15.50) 95.01 (13.79) 
Age of Illness Onset (years), mean (SD) 22.03 (5.10) 20.83 (5.42) 
PANSS Positive (T-score), mean (SD) 46.99 (8.07) 50.20 (5.42) 
PANSS Negative (T-score), mean (SD) 40.84 (8.30) 45.98 (9.73) 
PANSS General (T-score), mean (SD) 42.46 (7.22) 52.32 (9.58) 
Note. Premorbid IQ was estimated using the Wide Range Achievement Test-4 Reading subtest for 
Dataset One and the Wide Range Achievement Test-3 for Dataset Two. Only categorical data is 
available for educational attainment for Dataset Two; refer to Figure 1 for details. 
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 Figure 1. Frequency distribution of educational attainment of participants in dataset two 
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Table 2 
Cognitive, Capacity, and Outcome Measures Used in Two Archival Datasets 
Domain Dataset One Dataset Two 
Verbal Comprehension   
 Vocabulary (WASI); Vocabulary (WAIS-III); 
Processing Speed   
 Trail Making Test-Part A; 
Category Fluency; 
Symbol Coding (BACS); 
Symbol Search (WAIS-III); 
Category Fluency; 
Attention   
 Continuous Performance Test –
Identical Pairs; 
Conners’ Continuous 
Performance Test-II; 
Working Memory   
 Letter-Number Span (WAIS-III); 
Spatial Span (WMS-III); 
Letter-Number Sequencing 
(WAIS-III); 
Verbal Memory   
 Hopkins Verbal Learning Test-
Revised; 
California Verbal Learning 
Test-II; 
Visual Memory   
 Brief Visual Memory Test-
Revised; 
- 
Reasoning   
 Mazes (NAB); Matrix Reasoning (WAIS-III); 
Functional Capacity   
 University of California San 
Diego Performance-Based Skills 
Assessment Battery total score; 
Canadian Objective Assessment 
of Life Skills: 
• Procedural Knowledge; 
• Executive Operations; 
University of California San 
Diego Performance-Based 
Skills Assessment Battery 
total score; 
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Community Outcome   
 Multidimensional Scale of 
Independent Functioning: 
• Role Position; 
• Support; 
• Performance. 
Multidimensional Scale of 
Independent Functioning: 
• Role Position; 
• Support; 
• Performance. 
Note. BACS = Brief Assessment of Schizophrenia; NAB = Neuropsychological Assessment 
Battery; WAIS-III = Wechsler Adult Intelligence Scale III; WASI = Wechsler Abbreviated Scale 
of Intelligence. 
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Table 3 
Sample Correlation Matrix between Observed Variables (Dataset One) 
 Vocab TMT Fluency BACS CPT-IP LNS Spatial 
Span 
HVLT-R BVMT-R Mazes UPSA COALS 
PRK 
COALS 
EXO 
Vocab* 1.00             
TMT* 0.07 1.00            
Fluency* 0.43 0.41 1.00           
BACS* 0.34 0.53 0.41 1.00          
CPT-IP* 0.49 0.29 0.41 0.42 1.00         
LNS* 0.27 0.22 0.35 0.42 0.41 1.00        
Spatial Span 0.14 0.41 0.30 0.39 0.32 0.28 1.00       
HVLT-R* 0.44 0.27 0.40 0.41 0.36 0.41 0.44 1.00      
BVMT-R* 0.34 0.42 0.33 0.51 0.27 0.39 0.48 0.47 1.00     
Mazes 0.04 0.59 0.30 0.43 0.30 0.34 0.49 0.29 0.36 1.00    
UPSA* 0.45 0.24 0.33 0.40 0.38 0.45 0.34 0.45 0.38 0.24 1.00   
COALS PRK* 0.56 0.40 0.39 0.55 0.54 0.43 0.41 0.55 0.45 0.37 0.66 1.00  
COALS EXO* 0.47 0.46 0.43 0.50 0.49 0.42 0.38 0.44 0.41 0.40 0.63 0.74 1.00 
Note. N = 96. Vocab = Vocabulary; TMT = Trail Making Test (Part A); Fluency = Category Fluency (animals); BACS = Brief 
Assessment of Schizophrenia Symbol Coding; CPT-IP = Continuous Performance Test – Identical Pairs; LNS = Letter-Number 
Sequencing; HVLT-R = Hopkins Verbal Learning Test-Revised; BVMT-R = Brief Visual Memory Test-Revised; COALS = Canadian 
Objective Assessment of Life Skills; PRK = Procedural Knowledge; EXO = Executive Operations; UPSA = University of California 
San Diego (UCSD) Performance-Based Skills Assessment Battery.
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Figure 2. Parallel analysis of eigenvalues of the reduced correlation matrix (dataset one) 
 
 
 
Table 4 
Root Mean Squared Residuals of Models in Dataset One 
 RMR 
One-factor model .09 
Two-factor model .05 
Three-factor model .04 
Four-factor model .03 
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Table 5 
Oblimin-Rotated Factor Loadings and Communalities for a Two-Factor Model (Dataset One) 
 Factor 1 Factor 2 Communality 
Vocabulary .83 -.29 .55 
TMT* .01 .78 .61 
Fluency* .41 .25 .32 
BACS* .39 .44 .51 
CPT-II* .57 .10 .39 
LNS* .45 .18 .31 
Spatial Span .19 .51 .39 
HVLT-R* .56 .14 .41 
BVMT-R* .35 .38 .39 
Mazes -.01 .76 .57 
COALS PRK* .74 -.02 .54 
COALS EXO* .81 .11 .75 
UPSA* .70 .20 .65 
Note. TMT = Trail Making Test (Part A); Fluency = Category Fluency (animals); BACS = Brief 
Assessment of Schizophrenia Symbol Coding; CPT-IP = Continuous Performance Test – 
Identical Pairs; LNS = Letter-Number Sequencing; HVLT-R = Hopkins Verbal Learning Test-
Revised; BVMT-R = Brief Visual Memory Test-Revised; COALS = Canadian Objective 
Assessment of Life Skills; PRK = Procedural Knowledge; EXO = Executive Operations; UPSA 
= University of California San Diego (UCSD) Performance-Based Skills Assessment Battery. 
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Table 6 
Residual Correlation Matrix of a Two-Factor Solution (Dataset one) 
 Vocab TMT Fluency BACS CPT-IP LNS Spatial 
Span 
HVLT-
R 
BVMT-
R 
Mazes UPSA COALS 
PRK 
COALS 
EXO 
Vocab* 0.45             
TMT* -0.01 0.39            
Fluency* 0.13 0.07 0.68           
BACS* 0.03 0.04 0.02 0.49          
CPT-IP* 0.08 0.00 0.07 0.02 0.61         
LNS* -0.05 -0.09 0.04 0.04 0.06 0.69        
Spatial Span -0.04 -0.06 -0.02 -0.04 0.01 -0.02 0.61       
HVLT-R* 0.04 -0.05 0.05 -0.01 -0.04 0.05 0.11 0.59      
BVMT-R* 0.06 0.00 -0.01 0.07 -0.08 0.05 0.10 0.10 0.61     
Mazes -0.03 0.00 -0.02 -0.04 0.03 0.05 0.04 -0.01 -0.04 0.43    
UPSA* -0.06 -0.03 -0.04 -0.03 -0.07 0.06 0.03 -0.01 0.00 0.00 0.46   
COALS PRK* -0.01 0.01 -0.08 0.00 0.00 -0.04 0.00 -0.01 -0.04 0.01 0.03 0.25  
COALS EXO* -0.03 0.04 -0.02 -0.04 -0.01 -0.03 -0.04 -0.08 -0.06 0.01 0.05 0.05 .35 
Note. N = 96. Vocab = Vocabulary; TMT = Trail Making Test (Part A); Fluency = Category Fluency (animals); BACS = Brief 
Assessment of Schizophrenia Symbol Coding; CPT-IP = Continuous Performance Test – Identical Pairs; LNS = Letter-Number 
Sequencing; HVLT-R = Hopkins Verbal Learning Test-Revised; BVMT-R = Brief Visual Memory Test-Revised; COALS = Canadian 
Objective Assessment of Life Skills; PRK = Procedural Knowledge; EXO = Executive Operations; UPSA = University of California 
San Diego (UCSD) Performance-Based Skills Assessment Battery.
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Table 7 
Oblimin-Rotated Factor Loadings and Communalities for a One-Factor Model (Dataset One) 
 Factor 1 Communality 
Vocabulary .54 .30 
TMT* .56 .31 
Fluency* .58 .34 
BACS* .70 .49 
CPT-IP* .61 .38 
LNS* .57 .33 
Spatial Span .56 .32 
HVLT-R* .65 .42 
BVMT-R* .63 .39 
Mazes .53 .29 
COALS PRK* .66 .44 
COALS EXO* .82 .68 
UPSA* .78 .61 
Note. TMT = Trail Making Test (Part A); Fluency = Category Fluency (animals); BACS = Brief 
Assessment of Schizophrenia Symbol Coding; CPT-IP = Continuous Performance Test – 
Identical Pairs; LNS = Letter-Number Sequencing; HVLT-R = Hopkins Verbal Learning Test-
Revised; BVMT-R = Brief Visual Memory Test-Revised; COALS = Canadian Objective 
Assessment of Life Skills; PRK = Procedural Knowledge; EXO = Executive Operations; UPSA 
= University of California San Diego (UCSD) Performance-Based Skills Assessment Battery. 
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Table 8 
Residual Correlation Matrix of a One-Factor Solution of the Data (Dataset One) 
 Vocab TMT Fluency BACS CPT-IP LNS Spatial 
Span 
HVLT-
R 
BVMT-
R 
Mazes UPSA COALS 
PRK 
COALS 
EXO 
Vocab* 0.70             
TMT* -0.23 0.69            
Fluency* 0.12 0.09 0.66           
BACS* -0.04 0.14 0.01 0.51          
CPT-IP* 0.15 -0.05 0.05 -0.01 0.62         
LNS* -0.04 -0.10 0.02 0.02 0.05 0.67        
Spatial Span -0.17 0.09 -0.03 -0.01 -0.03 -0.05 0.68       
HVLT-R* 0.09 -0.09 0.02 -0.04 -0.04 0.04 0.07 0.58      
BVMT-R* -0.01 0.07 -0.03 0.07 -0.11 0.03 0.12 0.07 0.61     
Mazes -0.25 0.29 -0.01 0.06 -0.03 0.03 0.19 -0.05 0.03 0.71    
UPSA* 0.09 -0.13 -0.05 -0.07 -0.03 0.07 -0.04 0.02 -0.04 -0.12 0.56   
COALS PRK* 0.11 -0.06 -0.09 -0.03 0.03 -0.04 -0.06 0.01 -0.07 -0.07 0.12 0.32  
COALS EXO* 0.05 0.02 -0.03 -0.05 0.01 -0.03 -0.06 -0.07 -0.08 -0.02 0.11 0.10 .39 
Note. N = 96. Vocab = Vocabulary; TMT = Trail Making Test (Part A); Fluency = Category Fluency (animals); BACS = Brief 
Assessment of Schizophrenia Symbol Coding; CPT-IP = Continuous Performance Test – Identical Pairs; LNS = Letter-Number 
Sequencing; HVLT-R = Hopkins Verbal Learning Test-Revised; BVMT-R = Brief Visual Memory Test-Revised; COALS = Canadian 
Objective Assessment of Life Skills; PRK = Procedural Knowledge; EXO = Executive Operations; UPSA = University of California 
San Diego (UCSD) Performance-Based Skills Assessment Battery. 
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Table 9 
Oblimin-Rotated Factor Loadings and Communalities Values for the Exploratory Factor 
Analysis of a Three-Factor Model (Dataset One) 
 Factor 1 Factor 2 Factor 3 Communality 
Vocabulary .40 -.21 .56 .64 
TMT* .08 .75 -.10 .61 
Fluency* .05 .35 .39 .37 
BACS* .17 .51 .23 .52 
CPT-IP* .36 .14 .26 .40 
LNS* .23 .25 .23 .31 
Spatial Span .03 .57 .14 .40 
HVLT-R* .15 .27 .46 .47 
BVMT-R* -.02 .51 .38 .46 
Mazes .06 .74 -.11 .57 
COALS PRK* .75 -.06 .05 .55 
COALS EXO* .82 .05 .07 .79 
UPSA* .85 .10 -.10 .74 
Note. TMT = Trail Making Test (Part A); Fluency = Category Fluency (animals); BACS = Brief 
Assessment of Schizophrenia Symbol Coding; CPT-IP = Continuous Performance Test – 
Identical Pairs; LNS = Letter-Number Sequencing; HVLT-R = Hopkins Verbal Learning Test-
Revised; BVMT-R = Brief Visual Memory Test-Revised; COALS = Canadian Objective 
Assessment of Life Skills; PRK = Procedural Knowledge; EXO = Executive Operations; UPSA 
= University of California San Diego (UCSD) Performance-Based Skills Assessment Battery. 
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Table 10  
Residual Correlation Matrix of a Three-Factor Solution of the Data (Dataset One) 
Note. N = 96. Vocab = Vocabulary; TMT = Trail Making Test (Part A); Fluency = Category Fluency (animals); BACS = Brief 
Assessment of Schizophrenia Symbol Coding; CPT-IP = Continuous Performance Test – Identical Pairs; LNS = Letter-Number 
Sequencing; HVLT-R = Hopkins Verbal Learning Test-Revised; BVMT-R = Brief Visual Memory Test-Revised; COALS = Canadian 
Objective Assessment of Life Skills; PKR = Procedural Knowledge; EXO = Executive Operations; UPSA = University of California 
San Diego (UCSD) Performance-Based Skills Assessment Battery.
 Vocab TMT Fluency BACS CPT-IP LNS Spatial 
Span 
HVLT-
R 
BVMT-
R 
Mazes UPSA COALS 
PKR 
COALS 
EXO 
Vocab* 0.36             
TMT* 0.01 0.39            
Fluency* 0.07 0.08 0.63           
BACS* 0.00 0.04 -0.01 0.48          
CPT-IP* 0.05 0.01 0.05 0.01 0.60         
LNS* -0.07 -0.09 0.02 0.03 0.06 0.69        
Spatial Span -0.05 -0.06 -0.04 -0.05 0.01 -0.03 0.60       
HVLT-R* -0.02 -0.04 -0.02 -0.04 -0.06 0.03 0.09 0.53      
BVMT-R* 0.00 0.00 -0.08 0.03 -0.10 0.03 0.07 0.04 0.54     
Mazes 0.00 0.00 -0.01 -0.03 0.04 0.05 0.04 0.00 -0.04 0.43    
UPSA* -0.04 -0.04 -0.01 -0.02 -0.06 0.08 0.04 0.03 0.03 -0.01 0.44   
COALS PKR* 0.00 0.00 -0.05 0.01 0.00 -0.02 0.01 0.03 0.00 0.00 0.01 0.21  
COALS EXO* 0.01 0.02 0.03 -0.01 0.00 -0.01 -0.02 -0.02 0.00 -0.01 0.01 -0.01 .26 
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Table 11 
Inter-factor Correlations within the Three-Factor Model (Dataset One) 
 Factor1 Factor 2 Factor 3  
Factor 1 1.00    
Factor 2 .54 1.00   
Factor 3 .58 .20 1.00  
 
 
 
Table 12 
Oblimin-Rotated Factor Loadings and Communality Values for the Exploratory Factor Analysis 
of a Four-Factor Model (Dataset One) 
 Factor 1 Factor 2 Factor 3 Factor 4 Communality 
Vocabulary .09 -.05 .85 .01 .83 
TMT* .05 .86 -.01 .02 .79 
Fluency* -.06 .36 .43 .16 .41 
BACS* .16 .36 .16 .27 .51 
CPT-IP* .27 .15 .32 .08 .40 
LNS* .30 -.06 .00 .38 .34 
Spatial Span .09 .13 -.13 .60 .48 
HVLT-R* .11 -.08 .21 .57 .53 
BVMT-R* -.04 .17 .16 .56 .49 
Mazes .13 .46 -.19 .30 .52 
COALS PRK* .77 -.16 -.02 .12 .60 
COALS EXO* .75 .04 .11 .07 .78 
UPSA* .81 .18 .04 -.10 .74 
Note. N=96. TMT = Trail Making Test (Part A); Fluency = Category Fluency (animals); BACS 
= Brief Assessment of Schizophrenia Symbol Coding; CPT-IP = Continuous Performance Test – 
Identical Pairs; LNS = Letter-Number Sequencing; HVLT-R = Hopkins Verbal Learning Test-
Revised; BVMT-R = Brief Visual Memory Test-Revised; COALS = Canadian Objective 
Assessment of Life Skills; PRK = Procedural Knowledge; EXO = Executive Operations; UPSA 
= University of California San Diego (UCSD) Performance-Based Skills Assessment Battery. 
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Table 13 
Residual Correlation Matrix of a Four-Factor Solution of the Data (Dataset One) 
 Vocab TMT Fluency BACS CPT-IP LNS Spatial 
Span 
HVLT-R BVMT-
R 
Mazes UPSA COALS 
PRK 
COALS 
EXO 
Vocab* 0.17             
TMT* 0.00 0.21            
Fluency* 0.00 0.01 0.59           
BACS* -0.01 0.00 -0.01 0.49          
CPT-IP* 0.01 -0.02 0.03 0.02 0.60         
LNS* -0.02 -0.03 0.07 0.06 0.09 0.66        
Spatial Span 0.00 -0.01 0.00 -0.04 0.04 -0.08 0.52       
HVLT-R* 0.00 0.01 0.03 -0.02 -0.04 0.00 0.01 0.47      
BVMT-R* 0.01 0.02 -0.05 0.04 -0.08 0.01 0.02 0.00 0.51     
Mazes 0.00 0.00 0.00 -0.02 0.05 0.05 0.05 -0.02 -0.04 0.48    
UPSA* 0.00 0.01 0.03 -0.01 -0.04 0.04 0.00 -0.01 0.01 -0.03 0.40   
COALS PRK* 0.00 0.00 -0.05 0.02 0.01 -0.03 0.00 0.02 -0.01 0.00 0.00 0.22  
COALS EXO* 0.00 0.00 0.02 -0.02 0.00 0.00 0.00 -0.01 0.00 0.00 0.01 0.00 .26 
Note. N = 96. Vocab = Vocabulary; TMT = Trail Making Test (Part A); Fluency = Category Fluency (animals); BACS = Brief Assessment of 
Schizophrenia Symbol Coding; CPT-IP = Continuous Performance Test – Identical Pairs; LNS = Letter-Number Sequencing; HVLT-R = 
Hopkins Verbal Learning Test-Revised; BVMT-R = Brief Visual Memory Test-Revised; COALS = Canadian Objective Assessment of Life 
Skills; PRK = Procedural Knowledge; EXO = Executive Operations; UPSA = University of California San Diego (UCSD) Performance-Based 
Skills Assessment Battery. 
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Table 14 
Inter-factor Correlations within the Four-Factor Model (Dataset One) 
 Factor1 Factor 2 Factor 3 Factor 4  
Factor 1 1.00     
Factor 2 .61 1.00    
Factor 3 .42 .49 1.00   
Factor 4 .58 .35 .08 1.00  
 
 
 
Table 15 
Sample Correlation Matrix between Observed Variables (Dataset Two) 
 Vocab LNS Matrix Symbol 
Search 
CVLT-II Fluency CPT-II UPSA 
Vocab* 1.00        
LNS* 0.59 1.00       
Matrix* 0.51 0.55 1.00      
Symbol Search 0.36 0.47 0.47 1.00     
CVLT-II* 0.45 0.48 0.48 0.40 1.00    
Fluency* 0.36 0.22 0.30 0.45 0.30 1.00   
CPT-II* -0.16 -0.07 -0.16 -0.05 -0.12 0.06 1.00  
UPSA* 0.57 0.51 0.41 0.38 0.42 0.33 -0.17 1.00 
Note. N = 155. Vocab = Vocabulary; LNS = Letter-Number Sequencing; Matrix = Matrix 
Reasoning; CVLT-II = California Verbal Learning Test-II; Fluency = Category Fluency 
(animals); CPT-II = Conners’ Continuous Performance Test-II; UPSA = University of California 
San Diego (UCSD) Performance-Based Skills Assessment Battery. 
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Figure 3. Parallel analysis of eigenvalues of the reduced correlation matrix (dataset two) 
 
 
Table 16 
Root Mean Squared Residuals of Models in Dataset Two 
 RMR 
One-factor model .06 
Two-factor model .04 
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Table 17 
Factor Loadings and Communalities for the Two-Factor Model (Dataset Two) 
 Factor 1 Factor 2 Communality 
Vocabulary .80 -.05 .60 
Letter Number Sequencing .78 -.01 .59 
Matrix Reasoning .59 .16 .49 
Symbol Search .15 .63 .54 
CVLT-II .52 .15 .40 
Category Fluency -.05 .66 .40 
CPT-II -.35 .24 .07 
UPSA .67 .03 .47 
Note. N = 155. CVLT-II = California Verbal Learning Test-II; CPT-II = Conners’ Continuous 
Performance Test-II; UPSA = University of California San Diego (UCSD) Performance-Based 
Skills Assessment Battery 
 
Table 18 
Residual Correlation Matrix of a Two-Factor Solution (Dataset Two) 
 Vocab LNS Matrix Symbol 
Search 
CVLT-II Fluency CPT-II UPSA 
Vocab* 0.41        
LNS* 0.00 0.41       
Matrix* -0.01 0.02 0.51      
Symbol Search -0.05 0.05 0.03 0.46     
CVLT-II* -0.03 0.00 0.04 -0.01 0.60    
Fluency* 0.07 -0.08 -0.03 0.00 0.00 0.60   
CPT-II* 0.00 0.08 -0.05 -0.02 -0.02 0.05 0.93  
UPSA* 0.05 -0.01 -0.06 -0.01 -0.01 0.05 -0.05 0.53 
Note. N = 155. Vocab = Vocabulary; LNS = Letter-Number Sequencing; Matrix = Matrix 
Reasoning; CVLT-II = California Verbal Learning Test-II; Fluency = Category Fluency 
(animals); CPT-II = Conners’ Continuous Performance Test-II; UPSA = University of California 
San Diego (UCSD) Performance-Based Skills Assessment Battery.
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Table 19 
Factor Loadings and Communalities for the One-Factor Model (Dataset Two) 
 Factor 1 Communality 
Vocabulary .75 .57 
Letter Number Sequencing .76 .57 
Matrix Reasoning .70 .49 
Symbol Search .61 .37 
CVLT-II .64 .40 
Category Fluency .45 .20 
CPT-II -.16 .03 
UPSA .68 .46 
Note. N = 155. CVLT-II = California Verbal Learning Test-II; CPT-II = Conners’ Continuous 
Performance Test-II; UPSA = University of California San Diego (UCSD) Performance-Based 
Skills Assessment Battery. 
 
Table 20 
Residual Correlation Matrix of a One-Factor Solution (Dataset Two) 
 Vocab LNS Matrix Symbol 
Search 
CVLT-II Fluency CPT-II UPSA 
Vocab* 0.44        
LNS* 0.03 0.43       
Matrix* -0.01 0.02 0.51      
Symbol 
Search 
-0.09 0.02 0.04 0.63     
CVLT-II* -0.03 0.00 0.03 0.01 0.60    
Fluency* 0.02 -0.12 -0.01 0.18 0.01 0.80   
CPT-II* -0.04 0.05 -0.05 0.05 -0.01 0.13 0.97  
UPSA* 0.06 0.00 -0.07 -0.03 -0.01 0.02 -0.06 0.54 
Note. N = 155. Vocab = Vocabulary; LNS = Letter-Number Sequencing; Matrix = Matrix 
Reasoning; CVLT-II = California Verbal Learning Test-II; Fluency = Category Fluency 
(animals); CPT-II = Conners’ Continuous Performance Test-II; UPSA = University of California 
San Diego (UCSD) Performance-Based Skills Assessment Battery. 
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Table 21 
Measurement Model of Factor Loadings for the Accepted Two-Factor Solution (Dataset One) 
 
Generalized 
Cognition 
Visual Processing 
Speed and Attention 
Vocabulary .83  
Fluency* .41  
CPT-IP* .57  
LNS* .45  
HVLT-R* .56  
COALS PRK* .74  
COALS EXO* .81  
UPSA* .70  
BVMT-R* .35 .38 
BACS* .39 .44 
TMT*  .78 
Spatial Span  .51 
Mazes  .76 
Note. TMT = Trail Making Test (Part A); Fluency = Category Fluency (animals); BACS = Brief 
Assessment of Schizophrenia Symbol Coding; CPT-IP = Continuous Performance Test – 
Identical Pairs; LNS = Letter-Number Sequencing; HVLT-R = Hopkins Verbal Learning Test-
Revised; BVMT-R = Brief Visual Memory Test-Revised; COALS = Canadian Objective 
Assessment of Life Skills; PRK = Procedural Knowledge; EXO = Executive Operations; UPSA 
= University of California San Diego (UCSD) Performance-Based Skills Assessment Battery.
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Figure 4. Community outcome prediction model of dataset one 
Model fit: CFI = .90, TLI = .88, RMSEA = .08, SRMR = .07; R2 = .28; * = p < .05
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Table 22 
Correlations Between Exogenous Variables in Dataset One 
 Generalized 
Cognition 
Processing 
Speed 
Generalized Cognition   
Processing Speed .73**  
Education .34* .16 
Note. N = 95; * = p ≤ .05; ** = p ≤ .001 
 
 
 
 
Table 23 
Correlations Between Exogenous Variables in Dataset Two 
 Generalized 
Cognition 
Education Positive 
Symptoms 
Negative 
Symptoms 
Education  .42**    
Positive Symptoms -.19* -.06   
Negative Symptoms -.34** -.14* .01  
General Symptoms -.36** -.13 .52** .50** 
Note. N = 157; * = p ≤ .05; ** = p ≤ .00
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Figure 5. Community outcome prediction model of dataset two 
Model fit: CFI = .90, TLI = .86, RMSEA = .07, SRMR = .06; R2 = .52; * = p ≤ .05; ** = p ≤ .01; *** = p ≤ .001 
